About Bioceltix
Bioceltix is a company based in Wrocław (Poland) founded in 2017 by Lukasz Bzdzion. Bioceltix offers products and services including BCX-CM-J, BCX-CM-AD, and BCX-EM. Bioceltix operates in a competitive market with competitors including Gallant, eQcell, RevaTis, Vetherapy and J-ARM, among others.
- Headquarter Wrocław, Poland
- Founders Lukasz Bzdzion
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bioceltix.com
- Social LinkedIn
- Legal Name Bioceltix Sa
- Net Profit-$4.22 M (USD)-4.29as on Dec 31, 2025
- EBITDA-$4.63 M (USD)7.03as on Dec 31, 2025
- InvestorsLeonarto
& 1 more
Products & Services of Bioceltix
Bioceltix offers a comprehensive portfolio of products and services, including BCX-CM-J, BCX-CM-AD, and BCX-EM.
Treatment for arthritis in horses using stem cells.
Therapy for atopic dermatitis in dogs via stem cells.
Stem cell based drug for various animal conditions.
Funding Insights of Bioceltix
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Bioceltix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Bioceltix
Bioceltix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Leonarto and Infini.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovative technology startups are supported by Leonarto through investments. | – | leonarto.vc | Poland | |
Startup ideas are supported through capital investments by Infini. | – | infini.pl | - |
Investor details for Bioceltix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bioceltix
1 people are tracked at Bioceltix (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lukasz Bzdzion | Founder & CEO | Leadership |
Complete people profiles for Bioceltix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Bioceltix
Bioceltix is a publicly listed company on the GPW with ticker symbol BCX in Poland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Nov 2021
- Listed onGPW: BCX
- Listed entityBioceltix SA
- Exchange sectorHealth technology
- ISINPLBCLTX00019
- Share price72.40 PLN (+1.54% on the day) · 2026-10-09
- Market capitalisation394,449,641.00 PLN
- EPS (diluted, trailing year)-3.48 PLN
- Volume (last session)1,810
Financials of Bioceltix
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | – | -15.2M PLN | -16.6M PLN |
| 2024 | – | -14.5M PLN | -17.9M PLN |
| 2023 | – | -13.7M PLN | -15.4M PLN |
| 2022 | – | -8.9M PLN | -9.2M PLN |
| 2021 | – | -4.4M PLN | -5.8M PLN |
Detailed financial statements for Bioceltix
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Bioceltix
4 dated milestones of Bioceltix across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Bioceltix is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
- IPO Lists on the stock exchange (IPO).
Competitors of Bioceltix
Bioceltix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gallant, eQcell, RevaTis, Vetherapy and J-ARM, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gallant.com | 2018 | Los Angeles, United States | $61.46M | – | Stem cell storage for canine regenerative therapy is offered. | |
| eqcell.com | 2010 | Guelph, Canada | $4.6M | 8 | Stem cell therapies for animal health are developed. | |
| revatis.com | 2013 | Luxemburg, United States | – | – | Undifferentiated muscle-derived stem cells are obtained via patented micro-biopsy technology. | |
| vetherapy.co | 2015 | San Francisco, United States | $250,000 | – | Provider of stem cell therapies for pets | |
| j-arm.biz | 2006 | Osaka, Japan | – | – | Developer of lymphocyte therapy and stem cell therapy for dogs and cats | |
| vetbiobank.com | 2011 | – | $450,237 | – | Veterinary regenerative medicine | |
| nupsala.com | 2012 | Melton Mowbray, United Kingdom | $192,595 | 16 | Veterinary pharmaceuticals and products are supplied alongside educational resources. | |
| vetstem.com | 2002 | Poway, United States | – | – | Regenerative stem cell therapy for arthritis and injuries in dogs, cats, and horses. |
Detailed competitors of Bioceltix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bioceltix
The website of Bioceltix (bioceltix.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 25.3% vs previous month
Latest news on Bioceltix
Complete news archive for Bioceltix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Bioceltix
10 companies that operate in the same segment as Bioceltix (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioceltix
Bioceltix was founded in 2017.
Bioceltix is headquartered in Wrocław, Poland. It is registered at Wrocław, Lower Silesian Voivodeship, Poland.
Lukasz Bzdzion is the current CEO of Bioceltix. They have also founded this company.
Bioceltix is a developer of drugs for veterinary therapy. The company has developed MSC-based biological medications for treatment of illness in pets.
Bioceltix's top competitors include Gallant, eQcell and Vetbiobank.
Bioceltix offers BCX-CM-J, BCX-CM-AD, and BCX-EM.
Yes, Bioceltix is publicly traded on GPW under the ticker symbol BCX.
Bioceltix operates through Bioceltix Sa.